title: Epilogue: how will we care for patients with early arthritis?
abstract: This article draws conclusions about pinpointing the actual onset of disease and when interventions should start to occur. The identification of necessary biomarkers will be discussed. We will also examine the incremental consequences of delaying therapy, particularly for 'preclinical' disease. Medical economic analyses can help us balance benefits and avoid some adverse outcomes for patients. To conclude, we will discuss the new roles that need developing for primary care physicians and non-physican providers.
authors: Division of Rheumatology, Department of Medicine, Keck School of Medicine at the University of Southern California, USC Medical Center, IRD 427, 2010 Zonal Avenue, Los Angeles, CA 90033, USA. panush@usc.edu
authors: Richard S
authors: RS
authors: Panush
authors: Francisco P
authors: FP
authors: Quismorio
authors: David A
authors: DA
authors: Fox
mesh_terms: D001168:Arthritis / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D003695:Delivery of Health Care; D019468:Disease Management; D018450:Disease Progression; D042241:Early Diagnosis; D006801:Humans; D011379:Prognosis; D012219:Rheumatology / Q000379:methods*